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ABSTRACT SpontaneousCa21 release occurs in cardiac cells during sarcoplasmic reticulumCa21 overload, a processwe refer
to as store-overload-induced Ca21 release (SOICR). Unlike cardiac cells, skeletal muscle cells exhibit little SOICR activity. The
molecular basis of this difference is not well deﬁned. In this study, we investigated the SOICR properties of HEK293 cells
expressing RyR1 or RyR2. We found that HEK293 cells expressing RyR2 exhibited robust SOICR activity, whereas no SOICR
activity was observed in HEK293 cells expressingRyR1. However, in the presence of low concentrations of caffeine, SOICR could
be triggered in these RyR1-expressing cells. At the single-channel level, we showed that RyR2 is much more sensitive to luminal
Ca21 than RyR1. To identify the molecular determinants responsible for these differences, we constructed two chimeras between
RyR1andRyR2,N-RyR1(1–4006)/C-RyR2(3962–4968) andN-RyR2(1–3961)/C-RyR1(4007–5037).We found that replacing the
C-terminal region of RyR1 with the corresponding region of RyR2 (N-RyR1/C-RyR2) dramatically enhanced the propensity for
SOICR and the response to luminal Ca21, whereas replacing the C-terminal region of RyR2 with the corresponding region of
RyR1 (N-RyR2/C-RyR1) reduced the propensity for SOICR and the luminal Ca21 response. These observations indicate that the
C-terminal region of RyR is a critical determinant of both SOICR and the response to luminal Ca21. These chimeric studies also
reveal that the N-terminal region of RyR plays an important role in regulating SOICR and luminal Ca21 response. Taken together,
our results demonstrate that RyR1 differs markedly fromRyR2with respect to their responses to Ca21 overload and luminal Ca21,
and suggest that the lack of spontaneous Ca21 release in skeletal muscle cells is, in part, attributable to the unique intrinsic
properties of RyR1.
INTRODUCTION
Muscle contraction is initiated by the release of Ca21 from the
sarcoplasmic reticulum (SR) through the Ca21-release chan-
nel (ryanodine receptor, RyR). The mechanism by which SR
Ca21 release is triggered by membrane depolarization differs
in cardiac and skeletal muscle (1). In the heart, membrane
depolarization activates the cardiac L-type Ca21 channel, the
dihydropyridine receptor (DHPR), resulting in a small inﬂux
of Ca21. This Ca21 entry triggers a large Ca21 release from
the SR by opening the cardiac RyR (RyR2) via a mechanism
known as Ca21-induced Ca21 release (2). On the other hand,
Ca21 entry is not required for excitation-contraction (EC)
coupling in skeletal muscle. Depolarization-induced confor-
mational changes in the DHPR are believed to activate the
skeletal RyR (RyR1) via a direct physical interaction between
DHPR and RyR1 (1–3).
Besides their differences in EC coupling, cardiac and skel-
etal muscles also differ in their propensities for depolari-
zation-independent SR Ca21 release (spontaneous Ca21
release). It is well known that cardiac cells exhibit sponta-
neous Ca21 waves or oscillations in the absence of mem-
brane depolarization during SR Ca21 overload (4–8).
Considering its dependence on the SR Ca21 store, we have
referred to this depolarization-independent, Ca21 overload-
induced SR Ca21 release as store-overload-induced Ca21
release (SOICR) (9). It has long been recognized that SOICR
in cardiac cells can activate inward currents such as the Na1/
Ca21 exchanger current. These inward currents can alter the
surface membrane potential of cardiac cells and generate
delayed afterdepolarizations, which can lead to triggered
arrhythmia (10). Despite its important role in arrhythmo-
genesis, the molecular basis and regulatory mechanism of
SOICR are not well understood.
In contrast to cardiac cells, skeletal muscle cells show little
spontaneous Ca21 release (11–16). The reason for this lack
of spontaneous Ca21 release is unclear. Under certain con-
ditions, however, spontaneous Ca21 release can occur in
skeletal muscle. For example, treatments that disrupt the
sarcolemmal membrane or cause membrane deformations,
such as saponin permeabilization, mechanical skinning, or
osmotic shock, can induce spontaneous Ca21 release in skel-
etal muscle ﬁbers (16–20). Altering the metabolic and redox
states of mitochondria can also trigger spontaneous Ca21
release (21,22). These observations indicate that skeletal
muscle is susceptible to spontaneous Ca21 release. In line
with this view, spontaneous Ca21 release can also occur in
SR vesicles isolated from skeletal muscle (23–25). These
ﬁndings have led to the suggestion that spontaneous Ca21
release in intact skeletal muscle is actively suppressed (21,
26), though the exact molecular mechanism of this suppres-
sion is unknown. It has been proposed that the DHPR is an
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important suppressor of spontaneous Ca21 release in skeletal
muscle (27).
Skeletal and cardiac muscles express different subtypes
of DHPRs and RyRs with unique properties. These unique
properties are thought to be themajor determinants of the type
of EC coupling operating in cardiac and skeletal muscles (28).
The expression of RyR1 in dyspedic skeletal muscle cells
lacking endogenous RyR1 restores skeletal-type EC cou-
pling, whereas the expression of RyR2 in dyspedic skeletal
muscle cells does not restore skeletal type EC coupling, but
does support cardiac-type EC coupling (11,12). Interestingly,
spontaneous Ca21 waves and oscillations were observed in
dyspedic skeletal muscle cells expressing RyR2, but not in
cells expressing RyR1(11,12). These observations suggest
that theRyR isoform not only confers the type of EC coupling,
but also inﬂuences the occurrence of spontaneous Ca21 re-
lease. However, it remains to be determined whether differ-
ences in the intrinsic channel properties of RyR1 and RyR2
contribute to the different propensities for spontaneous Ca21
release observed in skeletal and cardiac muscles.
We recently showed that the sensitivity of the RyR2
channel to activation by luminal Ca21 is a critical determi-
nant of the threshold for SOICR (9). Disease-causing RyR2
mutations enhance the sensitivity of the channel to luminal
Ca21 activation and reduce the SOICR threshold (29). Con-
sidering the role of luminal Ca21 in SOICR, we propose that
the lack of SOICR activity in skeletal muscle may be
ascribed to the lesser response of RyR1 to luminal Ca21. To
test this hypothesis, we expressed RyR1 and RyR2 in an
equivalent cellular environment, HEK293 cells, which lack a
number of muscle-speciﬁc Ca21-handling proteins, and com-
pared their SOICR activity without the inﬂuence of DHPR.
We further determined the responses of RyR1 and RyR2 to
luminal Ca21 using single-channel recordings in planar lipid
bilayers. We found that SOICR occurred readily in HEK293
cells expressing RyR2, but not in cells expressing RyR1, and
that RyR2 is much more sensitive to luminal Ca21 than
RyR1. Moreover, we demonstrated that the C-terminal do-
main of RyR is a critical determinant of both SOICR and the
response to luminal Ca21, and that the N-terminal region of
RyR also plays an important regulatory role in these pro-
cesses. Our results suggest that the different responses of
RyR1 and RyR2 to luminal Ca21 contributes, in part, to the
different propensities for spontaneous Ca21 release observed
in cardiac and skeletal muscles.
MATERIALS AND METHODS
Construction of RyR1, RyR2, and
RyR1/RyR2 chimeras
The cDNA encoding the rabbit RyR1 was kindly provided by Dr. David H.
MacLennan (University of Toronto). The full-length mouse RyR2 cDNA
was cloned and constructed as described previously (30). An XhoI restriction
site was introduced into the mouse RyR2 at amino acid position 3961 by
site-directed mutagenesis (31). The XhoI-EcoRV cDNA fragment of RyR1
was removed and used to replace the corresponding fragment of RyR2 to
form the N-RyR2/C-RyR1 chimera. To produce the N-RyR1/C-RyR2
chimera, the XhoI-NotI fragment of RyR2 was removed and used to replace
the corresponding fragment of RyR1. All chimeric constructs were con-
ﬁrmed by DNA sequencing. The full-length RyR1, RyR2, and RyR1/RyR2
chimeras were subcloned into the mammalian expression vector pcDNA5
and used to generate stable, inducible HEK293 cell lines.
Generation of stable, inducible HEK293 cell lines
Stable, inducible HEK293 cell lines expressing RyR1, RyR2, and the
chimeras were generated using the Flp-In T-REx Core Kit from Invitrogen
(9) (Carlsbad, CA). Brieﬂy, the full-length cDNA encoding RyR1, RyR2, or
the chimeras was subcloned into the inducible expression vector, pcDNA5/
FRT/TO. Flp-In T-REx-293 cells were then cotransfected with the inducible
expression vector, pcDNA5/FRT/TO, containing the RyR1, RyR2, or RyR1/
RyR2 chimeric cDNAs and the pOG44 vector encoding the Flp recombinase
in 1:5 ratios using the Ca21 phosphate precipitation method. The transfected
cells were washed with phosphate-buffered saline (PBS) (137 mM NaCl, 8
mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM KCl) 1 day after transfection and
allowed to grow for one more day in fresh medium. The cells were then
washed again with PBS, harvested, and plated onto new dishes. After the
cells had attached (;4 h), the growth medium was replaced with a selective
medium containing 200 mg/ml hygromycin (Invitrogen). The selective me-
dium was changed every 3–4 days until the desired number of cells had
grown. These hygromycin-resistant cells were pooled, aliquoted, and stored
at –80C. These positive cells are believed to be isogenic, because the
integration of RyR cDNA is mediated by the Flp recombinase at a single
FRT site. Each HEK293 cell line was tested for RyR expression using
Western blotting and immunocytoﬂuorescence staining. The RyR protein
was detected in all cells examined.
Preparation of cell lysate, GST-FKBP12.6
pull-down, and immunoblotting analysis
Stable, inducible HEK293 cells grown for various durations after induction
by 1 mg/ml tetracycline were washed with PBS plus 2.5 mM EDTA and
harvested in the same solution by centrifugation for 8 min at 700 3 g in an
IEC Centra-CL2 centrifuge (International Equipment, Needham Heights,
MA). The cells were then washed with PBS without EDTA and centrifuged
again at 700 3 g for another 8 min. The PBS-washed cells were solubilized
in a lysis buffer containing 25 mM Tris/50 mM Hepes (pH 7.4), 137 mM
NaCl, 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), 0.5% soybean phosphatidylcholine, 2.5 mM DTT, and a protease
inhibitor mix (1 mM benzamidine, 2 mg/ml leupeptin, 2 mg /ml pepstatin A,
2 mg /ml aprotinin, and 0.5 mM PMSF). This mixture was incubated on ice
for 1 h. Cell lysate was obtained by centrifuging twice at 16,000 3 g in a
microcentrifuge at 4C for 30 min to remove the unsolubilized materials.
The cell lysates were then incubated with glutathione-Sepharose (15 ml) that
had been prebound with 60 mg GST-FKBP12.6 at 4C for 17–19 h. GST-
FKBP12.6 was produced using the pGEX-4T-1 GST Gene fusion System
(Pharmacia, Milan, Italy). The glutathione-precipitates were washed with
PBS three times, each time for 10 min. The proteins bound to the Sepharose
beads were then solubilized by the addition of 20 ml of 23 Laemmli’s
sample buffer plus 5% b-mercaptoethanol and boiled for 5 min. An equal
portion of the solubilized proteins from different samples was then separated
by 6% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis
(32). The SDS-polyacrylamide-gel-electrophoresis-resolved proteins were
transferred to nitrocellulose membranes at 45 V for 18–20 h at 4C in the
presence of 0.01% SDS according to the method of Towbin et al. (33). The
nitrocellulose membranes containing the transferred proteins were blocked
for 30 min with PBS containing 0.5% Tween-20 and 5% skim milk powder.
The blocked membrane was then incubated with the anti-RyR(34c), anti-
RyR1, or anti-RyR2 antibodies (34), and washed for 15 min three times,
with PBS containing 0.5% Tween-20. The membrane was then incubated
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with the secondary antimouse IgG (H&L) antibodies conjugated with
horseradish peroxidase (1:20,000) for 30 min. After washing for 15 min
three times, the bound antibodies were detected using an enhanced chemi-
luminescence kit from Pierce (Rockford, IL) (34).
Immunoﬂuorescent staining
Stable, inducible HEK293 cells were grown on glass coverslips placed in a
100-mm tissue culture dish. Twenty-four hours after induction by tetracy-
cline, the coverslips were washed three times with PBS, ﬁxed with 4%
formaldehyde in PBS for 15 min, and washed again, once with PBS and
three times with PBS containing 0.1% saponin, for 5 min each time. The
coverslips were blocked with buffer A (2% skim milk powder, 0.1% saponin
in PBS) for 30 min before washing and incubating with the anti-RyR
antibody (34c). The coverslips were then washed with buffer A and
incubated with rhodamine-conjugated antimouse IgG in buffer A for 1 h.
The coverslips were then washed, mounted in 95% glycerol, and analyzed
with a Leica DMRB ﬂuorescent microscope (Leica Microsystems, Wetzlar,
Germany) using a 403 objective.
Single-cell Ca21 imaging
Intracellular Ca21 transients in HEK293 cells expressing RyR1, RyR2, or
RyR1/RyR2 chimeras were measured using single-cell Ca21 imaging and
the ﬂuorescent Ca21 indicator dye fura-2 acetoxymethyl ester (fura-2 AM).
Brieﬂy, cells grown on glass coverslips for various durations after induction
by 1 mg/ml tetracycline (Sigma, St. Louis, MO) were loaded with 5mM fura-
2 AM in Krebs-Ringer-Hepes (KRH) buffer (125 mM NaCl, 5 mM KCl, 1.2
mM KH2PO4, 6 mM glucose, 1.2 mM MgCl2, 25 mM Hepes, pH 7.4) plus
0.02% pluronic F-127 (Molecular Probes, Eugene, OR) and 0.1 mg/ml BSA
for 20 min at room temperature. The coverslips were then mounted in a
perfusion chamber (Warner Instruments, Hamden, CT) on a Zeiss Axiovert
135 microscope (Carl Zeiss, Oberkochen, Germany) and continuously
perfused with KRH buffer containing various concentrations of CaCl2 (0.1–
10 mM) at room temperature. Fura-2 ﬂuorescence was captured every 4 s
through a Fluor 203 objective and a Chroma ﬁlter set using the Image-
Master System and a DeltaRAM rapid-wavelength-switching illuminator
(Photon Technology International, Lawrenceville, NJ). For measuring the
store Ca21 content, HEK293 cells expressing various RyR constructs were
perfused with KRH buffer containing different concentrations of Ca21 (0–
10mM). The cells were then challenged with 5 mM caffeine in the same
KRH perfusion buffer to assess the store Ca21 content at each [Ca21]o con-
centration. It should be noted that the stable, inducible HEK293 Flp-In cells
that express RyR1, RyR2, or the RyR1/RyR2 chimeras are all sensitive to
caffeine, whereas the parental HEK293 Flp-In cells that do not express RyRs
are caffeine-insensitive. We used caffeine to estimate the store Ca21 content
only in those cells that express RyRs.
Single-channel recordings
Recombinant RyR1, RyR2, and the RyR1/RyR2 chimeric proteins were
partially puriﬁed from cell lysate by sucrose density gradient centrifugation.
Heart phosphatidylethanolamine and brain phosphatidylserine (Avanti Polar
Lipids, Alabaster, AL), dissolved in chloroform, were combined in a 1:1
ratio (w/w), dried under nitrogen gas, and suspended in 30 ml of n-decane at
a concentration of 12 mg lipid/ml. Bilayers were formed across a 250-mm
hole in a Delrin partition separating two chambers. The trans chamber (800
ml) was connected to the head-stage input of an Axopatch 200A ampliﬁer
(Axon Instruments, Austin, TX). The cis chamber (1.2 ml) was held at
virtual ground. A symmetrical solution containing 250 mM KCl and 25 mM
Hepes (pH 7.4) was used for all recordings, unless indicated otherwise. A
4-ml aliquot ( 1 mg of protein) of the sucrose density gradient-puriﬁed
recombinant proteins was added to the cis chamber. Spontaneous channel
activity was always tested for sensitivity to EGTA and Ca21. The chamber
to which the addition of EGTA inhibited the activity of the incorporated
channel presumably corresponds to the cytoplasmic side of the Ca21-release
channel. The direction of single-channel currents was always measured from
the luminal to the cytoplasmic side of the channel, unless speciﬁed other-
wise. Recordings were ﬁltered at 2,500 Hz. Data analyses were carried out
using the pclamp 8.1 software package (Axon Instruments) (29). Free Ca21
concentrations were calculated using the computer program of Fabiato and
Fabiato (35).
RESULTS
Generation of stable, inducible HEK293 cell lines
expressing RyR1 and RyR2
It is possible that the different SOICR activities observed in
skeletal and cardiac muscle cells result from their different
cellular environments. Alternatively, since SR Ca21 release
is mediated by RyRs, it is also possible that this difference is
due to the different intrinsic properties of the RyR isoforms
expressed in skeletal muscle (RyR1) and cardiac muscle
(RyR2). To address these possibilities, we generated stable,
inducible HEK293 cell lines expressing RyR1 or RyR2 and
compared their SOICR properties in this equivalent non-
muscle cellular environment. The expression of RyR pro-
teins in these cell lines was conﬁrmed by immunoﬂuorescent
staining using an anti-RyR antibody (34c) that recognizes
both RyR1 and RyR2 (Fig. 1 A), and was further veriﬁed by
Western blotting using the anti-RyR antibody (34c) and an
RyR2-speciﬁc antibody. As shown in Fig. 1 B, the anti-RyR
antibody (34c) detected a high-molecular-weight band in the
HEK293 cell lines expressing RyR1 or RyR2, but not in
parental HEK293 cells (Fig. 1 B a). The major immunore-
active band detected in cells expressing RyR1 migrated
slightly more slowly than that from cells expressing RyR2
(Fig. 1 B a). Bands with lower molecular weights were also
detected in lysate from cells expressing RyR1, which pre-
sumably represent degradation products of RyR1. On the
other hand, the RyR2-speciﬁc antibody detected immunore-
active signals only in cells expressing RyR2, but not in cells
expressing RyR1 or in parental HEK293 cells (Fig. 1 B b).
HEK293 cells expressing RyR1 and RyR2 differ
markedly in SOICR
Having established the expression of RyR1 and RyR2 in
these stable, inducible HEK293 cell lines, we moved on to
assess their SOICR properties. Cells were loaded with fura-2
AM and perfused with elevating [Ca21]o. Single-cell Ca
21
imaging analysis revealed that elevating [Ca21]o as high as
10 mM did not induce SOICR in HEK293 cells expressing
RyR1 (Fig. 2, A and B). On the other hand, under the same
conditions SOICR was readily observed in HEK293 cells
expressing RyR2 (Fig. 2, A–C). As seen in HEK293 cells
expressing RyR2 (9), elevating [Ca21]o also increases the
store Ca21 content in HEK293 cells expressing RyR1 (Fig. 2
E). Furthermore, as reported with skeletal muscle cells,
SOICR could be triggered in HEK293 cells expressing RyR1
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in the presence of low concentrations of caffeine (0.5–0.7
mM) (Fig. 2 D) (11,15,36). These observations indicate that,
as in muscle cells, RyR2 is much more sensitive to Ca21
overload than RyR1 in an equivalent nonmuscle cellular
environment, suggesting that the intrinsic properties of the
RyR channels are critical determinants for the occurrence of
SOICR.
Single RyR1 and RyR2 channels exhibit different
responses to luminal Ca21
Considering that SOICR is triggered by SR Ca21 overload,
and that elevated SR luminal Ca21 activates RyR2, it is
likely that the different SOICR activities observed in RyR1-
and RyR2-expressing cells may be due to their different
responses to luminal Ca21. To test this hypothesis, we
examined the response of single RyR1 and RyR2 channels to
a wide range of luminal Ca21 concentrations. As shown in
Fig. 3, a single RyR2 channel was activated by ;300 nM
cytosolic Ca21 (Fig. 3 A a), and was inhibited by the addition
of EGTA (cytosolic) (Fig. 3 A b), which reduced cytosolic
Ca21 to ;45 nM. The luminal Ca21 was then increased
stepwise from 45 nM to 50 mM. At luminal Ca21 concen-
trations between 45 nM and ;1 mM, the activity of the
channel did not change much. Long opening events started to
appear at ;2.5 mM luminal Ca21 (Fig. 3 A c). Further
increases in luminal Ca21 led to a greater activation of the
channel. At 50 mM luminal Ca21, the channel was con-
siderably activated with an average open probability (Po) of
;0.5 (Fig. 3 A h). In contrast, under the same conditions,
single RyR1 channels hardly responded to increasing
luminal Ca21 concentrations (Fig. 3 B). These data indicate
that single RyR1 channels are much less sensitive to luminal
Ca21 than single RyR2 channels. Given the link between
SOICR and the luminal Ca21 activation of RyR, this lack of
response of RyR1 to luminal Ca21 likely contributes to the
absence of SOICR in cells expressing RyR1.
Generation of stable, inducible HEK293 cell lines
expressing RyR1/RyR2 chimeras
In an attempt to understand the molecular determinants under-
lying the different responses of RyR1 and RyR2 to SOICR
and luminal Ca21, we made two chimeric constructs. One
construct, N-RyR1/C-RyR2, encompassed the N-terminal
;4000 amino acid residues of RyR1 and the C-terminal
;1000 residues of RyR2, and the other, N-RyR2/C-RyR1,
was composed of the N-terminal region of RyR2 and the
C-terminal region of RyR1 (Fig. 4, A and B). The rationale
for the design of these chimeras was based on the ﬁnding
by Bhat et al. that the C-terminal ;1000 residues of RyR1
form a functional Ca21-release channel when expressed in
CHO cells (37). These chimeric constructs were used to gen-
erate stable, inducible HEK293 cell lines expressing N-RyR1/
C-RyR2 and N-RyR2/C-RyR1. The expression of these chi-
meras in HEK293 cells was conﬁrmed by immunoblotting.
As expected, an RyR1-speciﬁc antibody, anti-RyR1(13C2)
raised against a peptide sequence (aa 4478–4512) in the
C- terminal region of RyR1(38), reacted with RyR1 and the
N-RyR2/C-RyR1 chimera, but not with RyR2 or the N-RyR1/
C-RyR2 chimera (Fig. 4 C a), since the latter constructs did
not contain the epitope for anti-RyR1(13C2). On the other
hand, an RyR2-speciﬁc antibody, anti-RyR2, raised against a
peptide sequence (aa 4674–4697) in the C-terminal region of
RyR2, recognized RyR2 and the N-RyR1/C-RyR2 chimera,
but not RyR1 or the N-RyR2/C-RyR1 chimera (Fig. 4 C b),
as they lacked the epitope for the anti-RyR2 antibody.
Role of the C-terminal region of RyR in SOICR
The C-terminal region of RyR, which is believed to contain
the channel conduction pore, likely plays an important role in
FIGURE 1 Immunoﬂuorescent staining and Western blot analysis of
stable, inducible HEK293 cell lines expressing RyR1 or RyR2. (A) Stable,
inducible HEK293 cells were ﬁxed and permeabilized 24 h after induction
by tetracycline. RyR1 or RyR2 proteins were detected using anti-RyR
antibody and secondary rhodamine-conjugated antimouse IgG antibody.
Light (left) and ﬂuorescent (right) images are shown (scale bar, 10 mm). (B)
Cell lysates were prepared from parental HEK293 cells (HEK), RyR1-
expressing HEK293 cells (RyR1), and RyR2-expressing HEK293 cells
(RyR2). RyR proteins were pulled down by GST-FKBP12.6 from the same
amount of cell lysate. The GST-FKBP12.6 precipitates were immunoblotted
with anti-RyR antibody (a) or anti-RyR2 antibody (b).
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sensing luminal Ca21 and mediating SOICR. To test this
hypothesis, we compared the SOICR activity of HEK293
cells expressing RyR1 with that of cells expressing the
N-RyR1/C-RyR2 chimera. The N-RyR1/C-RyR2 chimera
differs from RyR1 in the C-terminal region (Fig. 4 A). To
ensure a similar level of expression of RyR1 and N-RyR1/
C-RyR2, we determined the time course of expression of the
N-RyR1/C-RyR2 chimera by immunoblotting using the anti-
RyR antibody that recognizes both RyR1 and the chimera.
As shown in Fig. 5 A, the level of expression of N-RyR1/
C-RyR2 after 6–9 h induction was similar to that of RyR1
after 24 h induction. Therefore, we compared SOICR be-
tween RyR1-expressing cells induced for 24 h and N-RyR1/
C-RyR2-expressing cells induced for 6 or 9 h. As seen in
Fig. 5, B and C, SOICR was readily observed in HEK293
cells expressing the N-RyR1/C-RyR2 chimera after 6 or 9 h
induction, whereas no SOICR was detected in cells express-
ing RyR1 after 24 h induction (Fig. 2 C). Thus, replacing the
C-terminal region of RyR1 with the corresponding region of
RyR2 confers SOICR activity.
To assess the impact of the C-terminal region of RyR1 on
SOICR, we compared the SOICR activity of HEK293 cells
expressing RyR2 with that of cells expressing the N-RyR2/
C-RyR1 chimera, which differs from RyR2 in the C-terminal
region (Fig. 4 A). Similarly, to ensure a comparable level of
expression of RyR2 and the N-RyR2/C-RyR1 chimera for
comparative studies, we determined the time course of ex-
pression of RyR2. The expression level of RyR2 after 12 h
induction was found to be similar to that of N-RyR2/C-RyR1
after 24 h induction (Fig. 6 A). SOICR was then compared
between cells expressing RyR2 after 12 h induction and cells
expressing the chimera after 24 h induction. As shown in
Fig. 6, SOICR occurred in HEK293 cells expressing RyR2 at
lower [Ca21]o than in cells expressing the N-RyR2/C-RyR1
chimera (Fig. 6, B and C). Furthermore, HEK293 cells ex-
pressing the N-RyR2/C-RyR1 chimera exhibited a reduced
propensity for SOICR compared to cells expressing RyR2
(Fig. 6 D). The fraction of oscillating cells in HEK293 cells
expressing the N-RyR2/C-RyR1 chimera was signiﬁcantly
lower than that in cells expressing RyR2 at [Ca21]o$ 0.2 mM
FIGURE 2 SOICR occurs in HEK293 cells
expressing RyR2, but not in cells expressing
RyR1, at elevated [Ca21]o. Stable, inducible
HEK293 RyR1 or RyR2 cells were induced
with tetracycline for 24 h and loaded with 5
mM fura-2 AM in KRH buffer at room
temperature for 20 min. Cells were perfused
continuously with KRH buffer containing 0.1–
10 mM Ca21 or 10mM Ca21 plus 5 mM
caffeine. (A) Fluorescent Ca21 images of single
RyR1 cells (upper) and RyR2 cells (lower) at
various [Ca21]o. (B) Fura-2 ratios of represen-
tative RyR1 (red) and RyR2 (blue) cells at
elevated [Ca21]o. (C) The fraction (%, mean6
SE) of RyR1 (solid circle) and RyR2 (open
circle) cells that displayed Ca21 oscillations at
various [Ca21]o. The total numbers of cells
analyzed for Ca21 oscillations were 389 for
RyR1 and 501 for RyR2 from four to six
separate experiments. (D) The fraction (%,
mean6 SE) of RyR1 cells that displayed Ca21
oscillations in the presence of 0.5 mM (open
circle) or 0.7 mM (solid circle) caffeine. The
total numbers of cells analyzed for Ca21
oscillations were 401 for cells treated with 0.5
mM caffeine and 454 with 0.7mM caffeine
from four separate experiments. (E) Store Ca21
content in HEK293 cells expressing RyR1 at
various [Ca21]o was estimated by measuring
the amplitude of caffeine (5 mM)-induced
Ca21 release and normalized to the maximum
level obtained at 10 mM [Ca21]o. Data shown
are mean 6 SE from three to six separate
experiments.
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(p , 0.05) (Fig. 6 D). Therefore, replacing the C-terminal
region of RyR2 with the corresponding region of RyR1
reduces the propensity for SOICR. Collectively, these data
indicate that the C-terminal region of RyR is a critical de-
terminant of SOICR. As observed in HEK293 cells ex-
pressing RyR1 or RyR2, elevating [Ca21]o also increased the
store Ca21 content in HEK293 cells expressing the N-RyR1/
C-RyR2 or the N-RyR2/C-RyR1 chimeras (Fig. 6 E).
Role of the N-terminal region of RyR in SOICR
Although the N-terminal region of RyR, which is thought to
form the cytoplasmic domain of the channel, is unlikely to
directly participate in sensing luminal Ca21 and mediating
SOICR, it may play a regulatory role in luminal Ca21
activation and SOICR. To test this possibility, we compared
the SOICR activity between HEK293 cells expressing RyR2
and cells expressing the N-RyR1/C-RyR2 chimera, and be-
tween cells expressing RyR1 and cells expressing N-RyR2/
C-RyR1. Each of these pairs differs in the N-terminal region
(Fig. 4 A). Under the same induction conditions (24 h), the
expression level of the N-RyR1/C-RyR2 chimera was com-
parable to that of RyR2 (Fig. 4 C b), whereas the expression
level of the N-RyR2/C-RyR1 chimera was slightly lower
than that of RyR1 (Fig. 4 C a). SOICR activities were com-
pared 24 h after induction. As shown in Fig. 7, SOICR
started to occur in HEK293 cells expressing the N-RyR1/
C-RyR2 chimera at 0.1–0.2 mM [Ca21]o (Fig. 7 A).
Interestingly, elevated [Ca21]o resulted in a marked increase
in basal intracellular Ca21 level and erratic Ca21 transients,
which were not observed in cells expressing RyR2. The
fraction of oscillating cells in HEK293 cells expressing the
N-RyR1/C-RyR2 chimera was signiﬁcantly higher than that
in cells expressing RyR2 at 0.2 mM external Ca21 or greater
(p, 0.05) (Fig. 7 B). Hence, replacing the N-terminal region
of RyR2 with the corresponding region of RyR1 enhances
FIGURE 3 Single RyR1 and RyR2
channels differ in their responses to
luminal Ca21. Single-channel activities
of RyR2 (A) and RyR1 (B) were
recorded in a symmetrical recording
solution containing 250 mM KCl and
25 mM Hepes (pH 7.4) at a holding
potential of20 mV. EGTA was added
to either the cis or trans chamber to
determine the orientation of the incor-
porated channel. The side of the chan-
nel to which an addition of EGTA
inhibited the activity of the incorpo-
rated channel presumably corresponds
to the cytoplasmic face. The incorpo-
rated channel was ﬁrst activated by 310
nM cytoplasmic Ca21 (a). The Ca21
concentration on both the cytoplasmic
and luminal side of the channel was
then adjusted to ;45 nM (b). The
luminal Ca21 concentration was then
increased to various levels by the
addition of aliquots of CaCl2 solution.
Single-channel current traces at 2.5 mM
(c), 5 mM (d), 10 mM (e), 20 mM (f),
and 40 mM (g) luminal Ca21 are
shown. The relationships between Po
and luminal Ca21 concentrations are
shown in h. Openings are downward.
Open probability (Po), arithmetic mean
open time (To), and arithmetic mean
closed time (Tc) are indicated on the top
of traces. A short line to the right of
each current trace indicates the base-
line. Data points shown are mean6 SE
from 10 single RyR2 and seven single
RyR1 channels.
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the propensity for SOICR. Similarly, compared to HEK293
cells expressing RyR1 (Fig. 2C), cells expressing the N-RyR2
/C-RyR1 chimera displayed enhanced SOICR activity (Fig.
6 D). In other words, replacing the N-terminal region of
RyR1 with the corresponding region of RyR2 also increases
the propensity for SOICR, even though the expression level
of N-RyR2/C-RyR1 is slightly lower than that of RyR1 (Fig.
5 C a). These observations indicate that regardless of the
isoform (either RyR1 or RyR2), changing the N-terminal
region of RyR leads to increased SOICR activity, suggesting
that the N-terminal region of RyR may normally play an
inhibitory role in SOICR in an isoform-speciﬁc manner.
Responses of the RyR1/RyR2 chimeras to
luminal Ca21
To determine whether the different SOICR activities ob-
served in HEK293 cells expressing different RyR1/RyR2
chimeras are linked to differences in their responses to lu-
minal Ca21, we examined the response of single RyR1/
RyR2 chimeric channels to a wide range of luminal Ca21
concentrations (45 nM to 50 mM). As shown in Fig. 8 A, a
single N-RyR1/C-RyR2 chimeric channel was activated
by ;300 nM cytosolic Ca21 and was inhibited when the
cytosolic Ca21 concentration was reduced to 45 nM. The
channel was then reactivated by increasing the luminal Ca21
FIGURE 4 Generation and characterization of RyR1/RyR2 chimeras.
(A) The linear sequences of RyR1 (solid box) and RyR2 (open box), and
the N-RyR1/C-RyR2 and N-RyR2/C-RyR1 chimeras are shown. An XhoI
restriction site was introduced into the RyR2 sequence at amino acid
position 3961, which corresponds exactly to the endogenous XhoI site in the
RyR1 sequence at position 4006. (B) Amino acid sequences around residues
4006 and 3961 in RyR1 and RyR2, respectively. (C) Western blot analysis
of stable inducible HEK293 cell lines expressing RyR1, RyR2, and the
chimeras. RyR proteins from the same amount of cell lysate were immu-
noblotted with anti-RyR1 antibody (a) and anti-RyR2 antibody (b).
FIGURE 5 RyR expression and SOICR in HEK293 cells expressing the
N-RyR1/C-RyR2 chimera. (A) Time course of N-RyR1/C-RyR2 protein
expression in HEK293 cells. N-RyR1/C-RyR2 HEK293 cells were induced
with tetracycline for different lengths of time (0–24 h). RyR1 cells were
induced for 24 h. RyR proteins from the same amount of cell lysate were
immunoblotted with anti-RyR antibody. (B and C) Fura-2 ratios of single
N-RyR1/C-RyR2 cells induced for 6 h and 9 h at elevated [Ca21]o. (D) The
fraction (%, mean 6 SE) of cells that display Ca21 oscillations at various
[Ca21]o, N-RyR1/C-RyR2 induced for 6 h (open circle), N-RyR1/C-RyR2
induced for 9 h (solid circle), and RyR1 induced for 24 h (open square). The
total numbers of cells analyzed for Ca21 oscillations were 496 (N-RyR1/
C-RyR2, 6 h), 520 (N-RyR1/C-RyR2, 9 h) and 389 (RyR1, 24 h) from four
to ﬁve separate experiments.
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concentration. Comparing their responses to luminal Ca21
revealed that single N-RyR1/C-RyR2 channels are much
more sensitive to luminal Ca21 than single RyR2 channels.
For example, at 300 mM luminal Ca21, single N-RyR1/
C-RyR2 channels exhibited an average Po of ;0.3, whereas
very little activity was observed with single RyR2 channels
at this luminal Ca21 concentration (Fig. 8 A h). On the other
hand, under the same conditions, single N-RyR2/C-RyR1
channels responded only weakly to elevated luminal Ca21
compared to single RyR2 channels (Fig. 8 B). However,
compared to single RyR1 channels, single N-RyR2/C-RyR1
channels were more sensitive to luminal Ca21 (Fig. 8 B h).
The results of these single-channel analyses are consistent
with those from studies of SOICR. RyR1, which has the
lowest response to luminal Ca21, also displays the lowest
propensity for SOICR, whereas the N-RyR1/C-RyR2 chi-
mera, which has the highest response to luminal Ca21, also
exhibits the highest propensity for SOICR. Overall, the
responsiveness of RyR1, RyR2, and the chimeras to luminal
Ca21 follow the same order as that of their propensities for
SOICR (i.e., RyR1, N-RyR2/C-RyR1, RyR2, N-RyR1/
C-RyR2). This close correlation between the luminal Ca21
response of the RyR isoform and the propensity for SOICR
of the cell line expressing it suggests that the latter is a
consequence of the former.
FIGURE 6 RyR expression and SOICR in HEK293 cells expressing
RyR2 and the N-RyR2/C-RyR1 chimera. (A) Western blot analysis of RyR
proteins in HEK293 cells expressing RyR2 or the N-RyR2/C-RyR1
chimera. HEK293 cells containing the RyR2 gene were induced by
tetracycline for different lengths of time, whereas cells containing the
chimera gene were induced for 24 h. RyR proteins from the same amount of
cell lysate were immunoblotted with anti-RyR antibody. (B and C) Fura-2
ratio of single RyR2 cells induced for 12 h (B) and of single N-RyR2/
C-RyR1 cells induced for 24 h (C) at elevated [Ca21]o. (D) The fraction (%,
mean 6 SE) of RyR2 cells (12 h induction, open circle) and N-RyR2/
C-RyR1 (24 h induction, solid circle) that display Ca21 oscillations at
various [Ca21]o. The total numbers of cells analyzed for Ca
21 oscillations
were 436 (RyR2, 12 h) and 876 (N-RyR2/C-RyR1, 24 h) from ﬁve to eight
separate experiments. (E) Store Ca21 content in HEK293 cells expressing
N-RyR1/C-RyR2 induced for 6 h or in HEK293 cells expressing N-RyR2/
C-RyR1 induced for 24 h at various [Ca21]o was estimated by measuring
the amplitude of caffeine (5 mM)-induced Ca21 release and normalized to
the maximum level obtained at 10 mM [Ca21]o. Data shown represent the
mean 6 SE from four separate experiments.
FIGURE 7 SOICR properties of HEK293 cells expressing the N-RyR1/
C-RyR2 chimera. (A) Fura-2 ratio of single N-RyR1/C-RyR2 cells induced
for 24 h at elevated [Ca21]o. (B) Comparison of the fraction (%, mean6 SE)
of RyR2 cells (open circle) and N-RyR1/C-RyR2 cells (solid circle) that
display SOICR activity at various [Ca21]o. The total numbers of cells
analyzed for Ca21 oscillations were 501 for RyR2 and 622 for N-RyR1/
C-RyR2 from ﬁve to six separate experiments.
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Fig. 8 also shows that the gating properties of the N-RyR1/
C-RyR2 chimera differ from those of the N-RyR2/C-RyR1
chimera. Single N-RyR1/C-RyR2 channels activated by
;300 nM cytosolic Ca21 displayed a mean open time of
;20 ms, which is much longer than that of single N-RyR2/
C-RyR1 channels (;0.5 ms). The mean open time of single
RyR2 channels activated by ;300 nM cytosolic Ca21 (;5
ms) was also much longer than that of single RyR1 channels
(;0.5 ms) (Fig. 3). Since N-RyR1/C-RyR2 and RyR2, and
N-RyR2/C-RyR1 and RyR1 share the same C-terminal
regions, respectively, these data indicate that the C-terminal
region of RyR contains not only the determinants for SOICR
and luminal Ca21 response, but also the determinants for
channel gating.
Effect of rapamycin on RyR1-expressing
HEK293 cells
HEK293 cells express a considerable amount of FKBP12.0,
which interacts speciﬁcally with RyR1, but not with RyR2,
and an undetectable level of FKBP12.6, which can bind to
both RyR1 and RyR2 (39,40). It is possible that the observed
differences in SOICR in HEK293 cells expressing RyR1 and
RyR2 could result from the speciﬁc interaction of FKBP12.0
with RyR1. To test this possibility, we examined SOICR in
cells expressing RyR1 that were treated with 10 mM
rapamycin, which dissociates FKBP12.0 from RyR1. As
shown in Fig. 9, HEK293 cells expressing RyR1 showed no
SOICR activity in either the absence or presence of 10 mM
rapamycin. These results suggest that the lack of SOICR in
FIGURE 8 Single chimeric N-RyR1/
C-RyR2 and N-RyR2/C-RyR1 chan-
nels exhibit different responses to lu-
minal Ca21. Single-channel activities
of N-RyR1/C-RyR2 (A) and N-RyR2/
C-RyR1 (B) were recorded in a symmet-
rical recording solution containing 250
mMKCl and 25 mMHepes (pH 7.4), as
described in the legend to Fig. 3. (A)
The control current traces for N-RyR1/
C-RyR2 at 310 nM cytoplasmic Ca21
are shown in a and single-channel
current traces at 45 nM (b), 2 mM (c),
100 mM (d), 600 mM (e), 2.5 mM ( f ),
and 5 mM (g) luminal Ca21 are also
depicted. (B) The control current traces
for N-RyR2/C-RyR1 are shown in a
and single-channel current traces at 45
nM (b), 2.5 mM (c), 5 mM (d), 10 mM
(e), 20 mM ( f ), and 40 mM (g) luminal
Ca21 are also shown. The holding po-
tential was20 mV. Openings are down-
ward. Open probability (Po), arithmetic
mean open time (To), and arithmetic
mean closed time (Tc) are indicated on
the top of traces. A short line to the right
of each current trace indicates the base-
line. The relationships between Po and
luminal Ca21 concentrations of single
N-RyR1/C-RyR2 (A h) and N-RyR2/
C-RyR1 (B h) channels are shown in
comparison with those of single RyR2
and RyR1 channels, respectively. Data
points shown are mean 6 SE from six
single N-RyR1/C-RyR2 and ﬁve single
N-RyR2/C-RyR1 channels.
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HEK293 cells expressing RyR1 is unlikely to be due to the
association of FKBP12.0 with RyR1.
DISCUSSION
In contrast to cardiac cells, skeletal muscle cells show little
SOICR (11–16). The reason for this difference is not
completely understood. We have recently shown that RyR2
is a key component governing SOICR, and that abnormal
RyR2 function can lead to altered SOICR (29). Based on these
observations, we propose that the lack of SOICR in skeletal
muscle cells may be attributable to the unique properties of
RyR1. In this study, we compared SOICR in HEK293 (non-
muscle) cells expressingRyR1orRyR2.Our results show that
SOICR occurs readily in HEK293 cells expressing RyR2,
whereas HEK293 cells expressing RyR1 display no SOICR
activity, although SOICR could be triggered in these cells in
the presence of caffeine. We also compared the responses of
single RyR1 and RyR2 channels to luminal Ca21, and dem-
onstrated that single RyR2 channels are much more sensitive
to luminal Ca21 than single RyR1 channels. These observa-
tions demonstrate that RyR1 and RyR2 differ in their
responses to Ca21 overload and luminal Ca21, and that these
differences may underlie, in part, the different propensities for
SOICR in cardiac and skeletal muscle cells.
Mechanisms regulating spontaneous SR Ca21
release in skeletal muscle cells
A unique feature of skeletal muscle cells distinguishing them
from cardiac cells is their lack of spontaneous Ca21-release
activity. This feature is perhaps related to the ability of
skeletal muscle to stay in a relaxed state for a long period of
time. To do so, skeletal muscle cells must be able to tightly
control Ca21 release from the SR via the RyR1 channel. This
tight control of SR Ca21 release is believed to be achieved by
the skeletal muscle DHPR, which physically interacts with
the RyR1 channel (1,28,41). It has been shown that the
skeletal muscle DHPR plays an important role not only in the
activation, but also in the termination of SR Ca21 release
(42). Furthermore, the suppression of spontaneous SR Ca21
release in skeletal muscle cells can be alleviated by removing
the transverse tubular membrane or by osmotic shock, which
is thought to cause membrane deformation and disrupt the
RyR1-DHPR interaction (16,17,19,20). In addition, dys-
genic muscle cells, which lack DHPR, do not exhibit sig-
niﬁcant repression of spontaneous SR Ca21 release (27).
Clearly, the DHPR is a major factor in the inhibition of
RyR1-mediated spontaneous Ca21 release in skeletal muscle
cells.
Spontaneous SR Ca21 release was also detected in
mechanically skinned skeletal muscle ﬁbers, a process that
is thought to leave the DHPR-RyR1 interaction intact (18).
This observation suggests that the presence of DHPR alone is
not sufﬁcient to completely suppress spontaneous Ca21 re-
lease, and that other factors are also involved in the sup-
pression (27). Moreover, suppression of RyR1 activity was
observed in SR vesicles that were devoid of the components
of the transversal tubular membrane including DHPR, further
indicating the existence of a DHPR-independent mechanism
of inhibiting spontaneous Ca21 release (43,44). Interestingly,
spontaneous SR Ca21 release was enhanced in skeletal
muscle ﬁbers after saponin permeabilization, inhibition of
mitochondrial function, or an elevation of cytosolic Ca21
concentrations (17,21,22,45). Each of these manipulations
can alter cytosolic Ca21 homeostasis andmay affect SR Ca21
loading. In line with this view, the impact of elevated
cytosolic Ca21 concentrations on spontaneous Ca21 release
manifested with a time delay, which is believed to be due to
the time required to load the SR (26). Taken together, these
observations suggest that the SR Ca21 load is another
important factor that inﬂuences the propensity for spontane-
ous Ca21 release in skeletal muscle cells.
Since RyR1 mediates SR Ca21 release in skeletal muscle,
it is logical to assume that the activity of RyR1 would have a
considerable impact on the propensity for spontaneous Ca21
release in skeletal muscle. Indeed, spontaneous Ca21 release
in skeletal muscle ﬁbers can be induced in the presence of
caffeine, an activator of RyR1 (11,15,36). It is known that in
cardiac cells, caffeine reduces the threshold SR Ca21 content
at which spontaneous Ca21 release occurs by increasing the
activity of the RyR2 channel (46). It is likely that by ac-
tivating RyR1, caffeine likewise reduces the threshold for
SOICR in skeletal muscle cells. The lack of spontaneous
Ca21 release in skeletal muscle cells in the absence of
caffeine may imply that they have a higher SOICR threshold
than cardiac cells. As a result, a considerable overloading of
FIGURE 9 Effect of rapamycin on the response of HEK293 cells
expressing RyR1 to elevating [Ca21]o. HEK293 cells expressing RyR1
grown on glass coverslips were induced with tetracycline for ;24 h and
loaded with 5 mM fura-2 AM in KRH buffer for 20 min at room temperature.
Cells were continuously perfused with KRH buffer containing 10 mM Ca21
with or without 10 mM rapamycin. Caffeine (5 mM) was applied at the end
of the experiment to trigger Ca21 release from the intracellular Ca21 store.
The trace shown is fura-2 ratios of a representative cell out of 178 cells from
three separate experiments.
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SR Ca21 and/or a reduction in the threshold (e.g., by caf-
feine) would be required to trigger spontaneous Ca21 release
in skeletal muscle. In line with this view, we observed
SOICR in HEK293 cells expressing RyR1 in the presence of
low concentrations of caffeine (Fig. 2). Taken together, the
mechanisms underlying the different SOICR behaviors of
skeletal and cardiac muscle cells are likely complex and
involve multiple factors. Nevertheless, differences in the
intrinsic properties of the RyR1 and RyR2 channels are
likely an important factor.
RyR1 and RyR2 exhibit different responses to
luminal Ca21
Why HEK293 cells expressing RyR1 and RyR2 differ in
their propensities for SOICR is not altogether clear. We have
shown that single RyR2 channels are much more sensitive
to luminal Ca21 than single RyR1 channels (Fig. 3). This
difference in their responses to luminal Ca21 is likely to con-
tribute to the different SOICR propensities observed in cells
expressing RyR1 and RyR2.
It should be noted that to speciﬁcally study and compare the
intrinsic properties of different RyR channels with respect to
luminal Ca21 regulation, in this study, we determined the
responses of single RyR1, RyR2, and RyR1/RyR2 chimeric
channels incorporated into planar lipid bilayers to a wide
range of luminal Ca21 concentrations under identical condi-
tions, without the presence of channel agonists, such as ATP,
caffeine, or sulmazole. Most of the previous studies on the
impact of luminal Ca21 on RyR channels incorporated into
lipid bilayers were carried out in the presence of channel
agonists to enhance luminal Ca21 activation (47–51). In the
absence of these channel agonists, single RyR channels
display little response to physiologically relevant concentra-
tions (1–2 mM) of luminal Ca21. Consistent with these
observations, we found that with Ca21 as the sole channel
activator, single RyR2 channels were considerably activated
only when the luminal Ca21 concentration was increased to
10mMor greater.However, under the same conditions, single
RyR1 channelswere hardly activated by luminal Ca21 even at
40mM.Hadwe included channel agonists in our protocol, the
luminal Ca21 load required to activate the channel would
have been more physiologically relevant, but the results
would have been confounded by the impossibility of dis-
cerning whether differences between isoforms were attribut-
able to different sensitivities to luminal Ca21 or to different
sensitivities to the agonists.
Although it is clear that the RyR1 and RyR2 channels
respond differently to luminal Ca21, precisely how luminal
Ca21 activates RyR1 and RyR2 to different extents is not. It
has been suggested that luminal Ca21 activates RyRs by
passing through the open channel and acting on the cytosolic
Ca21 activation site (a ‘‘feed-through’’ regulation hypoth-
esis) (47,49). Thus, it is possible that the different responses
of RyR1 and RyR2 to luminal Ca21 could result from their
different sensitivities to cytosolic Ca21. However, the role of
the luminal-to-cytosolic Ca21 ﬂuxes in the activation of RyR
by luminal Ca21 is controversial. Gyorke et al. and Ching
et al. found that luminal-to-cytosolic Ca21 ﬂuxes are not
necessary for the activation of RyR by luminal Ca21 (50,51).
Furthermore, the application of trypsin to the luminal side of
the RyR channels diminishes luminal Ca21 activation, but
not Ca21 ﬂuxes, arguing against the ‘‘feed-through’’ mech-
anism and suggesting the existence of a luminal Ca21
regulation site distinct from the cytosolic Ca21 activation site
(51). Hence, the different responses of RyR1 and RyR2 to
luminal Ca21 could result from their different sensitivities to
luminal Ca21. Alternatively, luminal Ca21 may bind to the
putative luminal Ca21 sensor and sensitize the channel to
activation by cytosolic Ca21 in an allosteric manner. This
allosteric regulation of the channel by luminal Ca21 could be
further modulated by other ligands, such as Mg21, which is
known to inhibit the RyR1 channel more potently than the
RyR2 channel. Therefore, the different responses of RyR1
and RyR2 to luminal Ca21 and Ca21 overload could result
from differences in their allosteric regulation by luminal
Ca21. Clearly, further systematic and detailed studies are
required to deﬁne the exact mechanism underlying the
luminal Ca21 activation of RyRs.
The activation of RyR2 by luminal Ca21 is likely
modulated by a number of factors. It has been proposed that
calsequestrin, a low-afﬁnity, high-capacity SR Ca21-binding
protein, acts as a luminal Ca21 sensor and is responsible for
the activation of RyR2 by luminal Ca21 (52). However, this
view is apparently inconsistent with the observation that
puriﬁed native RyRs remain sensitive to luminal Ca21 ac-
tivation (48,49).Moreover, recent studies have shown that SR
Ca21 release in cardiac myoctyes isolated from calsequestrin
knock-out mice remains steeply nonlinear with increasing SR
Ca21 content, indicating that the RyR2 channel can sense
luminal Ca21 in the absence of calsequestrin. These obser-
vations have led to the conclusion that calsequestrin, although
itmodulates SRCa21 release, is not required for luminal Ca21
sensing (53). Consistent with this ﬁnding, we found that
recombinant RyR2 expressed in HEK293 cells, which lack
calsequestrin, is activated by luminal Ca21.
Molecular determinants of SOICR and luminal
Ca21 response
We took advantage of the marked differences between RyR1
and RyR2 to identify regions in the RyR channel that are
important for SOICR and luminal Ca21 response by con-
structing chimeras between RyR1 and RyR2. Although the
C-terminal region of RyR is likely to be the region respond-
ing to SR luminal Ca21 (48), as it is thought to be the trans-
membrane, channel pore-forming region that has access to
luminal Ca21, this hypothesis has yet to be tested directly. Our
chimeric studies demonstrated that replacing the C-terminal
region of RyR1with the corresponding region of RyR2
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(N-RyR1/C-RyR2) dramatically enhanced the response of
the channel to luminal Ca21. Signiﬁcant activation of single
N-RyR1/C-RyR2 channels was already detected at 2–100 mM
luminal Ca21 (Fig. 8 A). In accordance with this observation,
HEK293 cells expressing the N-RyR1/C-RyR2 chimera
displayed SOICR even at 0.1 mM [Ca21]o. Elevating [Ca
21]o
also caused a steady increase in the resting Ca21 level (Figs.
5 C and 7 A). The exact mechanism for this increase is not
clear. We found that decreasing the expression level of
N-RyR1/C-RyR2 by reducing the induction time decreased
the cytoplasmic Ca21 level upon elevating [Ca21]o, com-
paring Fig. 5 B (with 6 h induction) with Fig. 7 A (with 24 h
induction). It should be noted that at a comparable level of
expression, RyR2-expressing cells do not display a marked
increase in the cytoplasmic Ca21 level in response to ele-
vating [Ca21]o. These observations suggest that the increase
in the cytoplasmic Ca21 in N-RyR1/C-RyR2-expressing
cells may result from severe spontaneous Ca21 release from
N-RyR1/C-RyR2, which is beyond the capacity of the Ca21-
ATPase, thus leading to an elevated resting Ca21 level.
In contrast to the N-RyR1/C-RyR2 chimera, the N-RyR2/
C-RyR1 chimera, in which the C-terminal region of RyR2
was replaced with the corresponding region of RyR1, ex-
hibited a reduced luminal Ca21 response and propensity for
SOICR (Fig. 6). In other words, the transfer of the C-terminal
region of RyR1 into the corresponding region of RyR2
confers a ‘‘low-response’’ phenotype to RyR2, whereas, the
transfer of the C-terminal region of RyR2 into the corre-
sponding region of RyR1 confers a ‘‘high-response’’ pheno-
type to RyR1. On the other hand, replacing the N-terminal
region of RyR2 with the corresponding region of RyR1 did
not give rise to a channel with a low-response phenotype, as
seen in RyR1. Similarly, replacing the N-terminal region of
RyR1 with the corresponding region of RyR2 did not result
in a channel with a high-response phenotype, as seen in
RyR2. These observations suggest that the N-terminal re-
gions of RyR1 and RyR2 are unlikely to be responsible for
the low- and high-response phenotypes of RyR1 and RyR2,
respectively. Taken together, these results indicate that the
C-terminal region of RyR is an essential determinant of
SOICR and the response to luminal Ca21.
The chimeric studies also revealed some interesting new
insight into the role of the N-terminal region of RyR in
SOICR and luminal Ca21 response. If the C-terminal region
of RyR were the sole determinant, one would expect that the
response to luminal Ca21 and the propensity for SOICR of
RyR2 and N-RyR1/C-RyR2 and of RyR1 and N-RyR2/
C-RyR1 would be similar, as they share the same C-terminal
region. However, this is not the case. Replacing the N-terminal
region of RyR2 with the corresponding region of RyR1
led to an augmented luminal Ca21 response and propen-
sity for SOICR compared to RyR2. Similarly, replacing the
N-terminal region of RyR1 with the corresponding region
of RyR2 resulted in an increased luminal Ca21 response and
propensity for SOICR compared to RyR1. These observa-
tions indicate that the N-terminal region of RyR also plays
an important role in SOICR and luminal Ca21 response.
It has been suggested that the cytoplasmic (N-terminal)
domain of RyR interacts with its transmembrane (C-terminal)
domain (54). This domain-domain interaction is likely to be
isoform-speciﬁc, and if so, should be weakened or abolished
in the N-RyR1/C-RyR2 and N-RyR2/C-RyR1 chimeras.
Since we observed enhanced activities when exchanging the
cytoplasmic regions between isoforms, the cytoplasmic re-
gion in intact RyR1 and RyR2 is likely involved in the
suppression of SOICR and luminal Ca21 regulation. Based on
this reasoning, we propose that the increased SOICR activity
and luminal Ca21 responsiveness observed with the N-RyR1/
C-RyR2 and N-RyR2/C-RyR1 chimeras result from the
disruption of the interaction between the cytoplasmic and
transmembrane domains, thus relieving the suppression nor-
mally exerted on RyR by its cytoplasmic region. It is likely
that the transmembrane region of RyR mediates SOICR and
luminal Ca21 response. However, it remains to be determined
whether the cytoplasmic region is able to modulate SOICR
and luminal Ca21 response by interacting with the transmem-
brane region in an isoform-speciﬁc manner.
Implications of SOICR in muscular diseases
We recently showed that a number of naturally occurring
RyR2 mutations linked to cardiac arrhythmia and sudden
death enhance the sensitivity of the channel to activation by
luminal Ca21 and reduce the threshold for SOICR (29).
Enhanced SOICR has also been observed in isolated cardiac
cells and muscles from failing, hypertrophied, and ischemic/
reperfused hearts (10). Altered RyR2 function, and partic-
ularly luminal Ca21 activation, is likely a common cause of
increased SOICR in many cardiac conditions. Given its po-
tential to induce delayed afterdepolarizations, increased SOICR
would enhance the propensity for triggered arrhythmia.
The link between SOICR and various cardiac diseases
suggests that enhanced SOICR may also be involved in
skeletalmuscle diseases. Indeed, enhanced spontaneous Ca21
release has been shown in skeletal muscle cells from patients
susceptible to malignant hyperthermia (MH) and central core
disease (CCD) and in skeletal muscle cells expressing MH/
CCD mutations (55,56). Furthermore, it has recently been
shown that intact skeletal muscle ﬁbers from dystrophic mice
display enhanced localized Ca21 transients (Ca21 sparks) un-
der hypertonic or hypotonic conditions (20). Thus, enhanced
SOICR may also be common to various skeletal muscle con-
ditions. In addition, our results suggest that the N-terminal
region also plays an important role in the regulation of RyR
by luminal Ca21. It has been shown that disease-linked RyR2
mutations in the N-terminal, central, and C-terminal regions
alter the sensitivity of the channel to luminal Ca21 activation.
How these mutations, and especially those located in the
N-terminal and central regions, affect luminal Ca21 activation is
not clear. Some of the disease-linked mutations may affect
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the mechanism by which the N-terminal region regulates
luminal Ca21 response.
In summary, we have demonstrated that RyR1 and RyR2
have different responses to Ca21 overload and luminal Ca21.
The C-terminal region of RyR is not only an essential de-
terminant for SOICR and luminal Ca21 response, but also a
determinant for channel gating, whereas the N-terminal re-
gion plays an important regulatory role in SOICR and luminal
Ca21 response. The intrinsic properties of the RyR1 and
RyR2 channels likely contribute to the different propensities
for SOICR observed in skeletal and cardiac muscle cells.
As in RyR2-associated cardiac arrhythmia, altered luminal
Ca21 response of RyR1 may be involved in skeletal muscle
abnormalities, such as MH, CCD, and muscular dystrophy.
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